Radioiodine remnant ablation: current indications and dosing regimens
BR Haugen - Endocrine Practice, 2012 - Elsevier
Objective To review and comment on current indica tions for radioiodine remnant ablation
(RRA) in patients with differentiated thyroid cancer. Methods The stratification of patients as …
(RRA) in patients with differentiated thyroid cancer. Methods The stratification of patients as …
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
B Biondi, M Pulcrano, L Pagano… - Biologics: Targets and …, 2009 - Taylor & Francis
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-
stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was …
stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was …
[HTML][HTML] Less than 2% of the low-and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan
L Agate, F Bianchi, F Brozzi, P Santini… - European Thyroid …, 2019 - etj.bioscientifica.com
Background: Recently, there has been a trend to reduce the use of radioiodine remnant
ablation (RRA) in patients with low-risk (LR) and intermediate-risk (IR) differentiated thyroid …
ablation (RRA) in patients with low-risk (LR) and intermediate-risk (IR) differentiated thyroid …
Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low …
J Lee, MJ Yun, KH Nam, WY Chung, EY Soh, CS Park - Thyroid, 2010 - liebertpub.com
Background: Few reports have examined the use of recombinant human thyroid-stimulating
hormone (rhTSH) for ablation of postsurgical thyroid remnants after low-dose radioactive …
hormone (rhTSH) for ablation of postsurgical thyroid remnants after low-dose radioactive …
[PDF][PDF] Prospective randomized trial for evaluation of efficacy of low versus high dose I-131 for post operative remnant ablation in differentiated thyroid cancer
S Sirisalipoch, V Buachum, P Pasawang… - 2006 - cuir.chula.ac.th
นิพนธ์ต้นฉบับศศิธร เล่ม 10 Volume 50 หน้า 695 - 706.pmd Page 1 Chula Med J Vol. 50 No. 10
October 2006 Sirisalipoch S, Buachum V, Pasawang P, Tepmongkol S, Boonvisut S …
October 2006 Sirisalipoch S, Buachum V, Pasawang P, Tepmongkol S, Boonvisut S …
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human …
R Elisei, M Schlumberger, A Driedger… - The Journal of …, 2009 - academic.oup.com
Background: We previously demonstrated comparable thyroid remnant ablation rates in
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
A randomized equivalence trial to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancer
Objective We conducted a stratified randomized equivalence/noninferiority trial from January
2001 to December 2006 to determine whether lower administered activities are as effective …
2001 to December 2006 to determine whether lower administered activities are as effective …
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide …
D Barbaro, M Grosso, G Boni, P Lapi… - European journal of …, 2010 - Springer
Background and aim Recombinant human TSH (rhTSH) can be used for post-surgical
radioiodine (I-131) thyroid remnants ablation in differentiated thyroid cancer (DTC) patients …
radioiodine (I-131) thyroid remnants ablation in differentiated thyroid cancer (DTC) patients …
[HTML][HTML] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
B Long, L Li, L Yao, S Chen, H Yi, X Ye… - Journal of Cancer …, 2015 - journals.lww.com
Purpose: To determine whether postoperative radioiodine (RAI) combined with
radiofrequency ablation (RFA) is an effective, safe, and feasible method for elimination of …
radiofrequency ablation (RFA) is an effective, safe, and feasible method for elimination of …
[HTML][HTML] Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid …
CRS Higuchi, P Fernanda, PA Jurnior… - Frontiers in Nuclear …, 2021 - frontiersin.org
Background: To effectively treat differentiated thyroid carcinoma (DTC) with radioiodine
therapy (RAI), it is necessary to raise serum thyrotropin levels, either by thyroid hormone …
therapy (RAI), it is necessary to raise serum thyrotropin levels, either by thyroid hormone …